About the Authors
- Michelle L. Scalley-Kim
-
Affiliation Department of Protein Engineering, VLST Corporation, Seattle, Washington, United States of America
- Bruce W. Hess
-
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
- Ryan L. Kelly
-
Affiliation Department of Protein Sciences, VLST Corporation, Seattle, Washington, United States of America
- Anne-Rachel F. Krostag
-
Current address: Department of Molecular Networks, Allen Institute for Brain Science, Seattle, Washington, United States of America
Affiliation Department of Protein Engineering, VLST Corporation, Seattle, Washington, United States of America
- Kurt H. Lustig
-
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
- John S. Marken
-
Affiliation Department of Protein Engineering, VLST Corporation, Seattle, Washington, United States of America
- Pamela J. Ovendale
-
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
- Aaron R. Posey
-
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
- Pamela J. Smolak
-
Affiliation Department of Protein Engineering, VLST Corporation, Seattle, Washington, United States of America
- Janelle D. L. Taylor
-
Current address: Department of Research, Oncothyreon Inc., Seattle, Washington, United States of America
Affiliation Department of Protein Engineering, VLST Corporation, Seattle, Washington, United States of America
- C. L. Wood
-
Current address: Department of Discovery Research, Omeros Corporation, Seattle, Washington, United States of America
Affiliation Department of Protein Engineering, VLST Corporation, Seattle, Washington, United States of America
- David L. Bienvenue
-
Affiliation Department of Protein Sciences, VLST Corporation, Seattle, Washington, United States of America
- Peter Probst
-
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
- Ruth A. Salmon
-
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
- Daniel S. Allison
-
Current address: Department of Antibody Technologies, Alder Biopharmaceuticals Inc., Bothell, Washington, United States of America
Affiliation Department of Protein Engineering, VLST Corporation, Seattle, Washington, United States of America
- Teresa M. Foy
-
* E-mail: tfoy@vlstcorp.com
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
- Carol J. Raport
-
Affiliation Department of Immunology and Preclinical Pharmacology, VLST Corporation, Seattle, Washington, United States of America
Competing Interests
The authors have read the journal’s policy and have the following conflicts: Dr. Foy is an employee of VLST Corporation and they provided funding for this study. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. MLS-K, A-RFK, JDT, CLW, and DSA contributed to this work while employees of VLST Corporation. These individuals are currently affiliated with other commercial or academic entities. Their current and former affiliations do not alter their adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MLS-K DLB PP RAS DSA TMF CJR. Performed the experiments: MLS-K BWH RLK A-RFK KHL JSM PJO ARP PJS JDLT CLW CJR. Analyzed the data: MLS-K DSA TMF CJR. Wrote the paper: MLS-K TMF CJR.